関連する実験動画
Updated: Feb 21, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
8.3K
シンガポールの高齢者における多発性合併症:ポリクリニックデータを用いた横断的な研究
Victoria Koh1, Shilpa Tyagi1,2, Gerald Choon-Huat Koh1,2
1MOH Office for Healthcare Transformation (MOHT), Singapore.
Journal of multimorbidity and comorbidity
|February 20, 2026
まとめ
マルチモルビリティは,シンガポールの高齢者の約60%に影響します.
科学分野:
- ゲロントロジーはゲロントロジーの学科です.
- 公衆衛生は公衆衛生である.
- エピデミオロジー エピデミオロジー
背景:
- 複数の慢性疾患の同時発生である多発症は,初等医療における懸念が高まっている.
- 現存する研究では,ダイアードとトライアードを超えた複雑な多病性組合せがしばしば見過ごされている.
研究 の 目的:
- シンガポールのプライマリケア環境における高齢者の多発性疾患の有病率と特定の組み合わせを決定する.
- ターゲットを絞った介入のために,一般的な高価な多病性パターンを特定する.
主な方法:
- 50歳以上の50万人以上のポリクリニック患者の横断分析.
- マルチモルビディティを定義するために,23の慢性疾患のカテゴリーで2012年まで診断を活用しました.
- 観察されたすべての多重病変性の組み合わせとその流行率を分析した.
主要な成果:
- 高齢者の約60% (59.9%) が多発性疾患を発症しました.
- 50万2,036人の患者の間で1万3,900以上のユニークな多病性組み合わせが特定されました.
- 最も一般的な組み合わせは3〜4つの疾患を含み,しばしば高脂血症,高血圧,糖尿病を含む.
結論:
- ハイパーリピデミアと高血圧は,流行し,高価なマルチ疾患の組み合わせの重要な構成要素です.
- 現在の疾患特異的管理は不十分である可能性があるので,一般的な多病性パターンの治療を最適化することが推奨される.
関連する概念動画
Drug Dosing: Geriatric Patients
306
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
306
Pharmacodynamics in Geriatric Patients: Effects of Age
254
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
254
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
283
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
283
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
744
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
744
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
245
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
245
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
272
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
272

